187 related articles for article (PubMed ID: 12957358)
21. Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus.
Hamoui N; Peters JH; Schneider S; Uchida K; Yang D; Vallböhmer D; Hagen JA; DeMeester SR; DeMeester TR; Danenberg K; Danenberg P
Arch Surg; 2004 Jul; 139(7):712-6; discussion 716-7. PubMed ID: 15249402
[TBL] [Abstract][Full Text] [Related]
22. Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophageal squamous cell carcinoma.
Wang X; Li X; Zhang X; Fan R; Gu H; Shi Y; Liu H
Eur J Surg Oncol; 2015 Oct; 41(10):1293-9. PubMed ID: 26329784
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 expression in oral squamous cell carcinoma.
Pannone G; Bufo P; Caiaffa MF; Serpico R; Lanza A; Lo Muzio L; Rubini C; Staibano S; Petruzzi M; De Benedictis M; Tursi A; De Rosa G; Macchia L
Int J Immunopathol Pharmacol; 2004; 17(3):273-82. PubMed ID: 15461861
[TBL] [Abstract][Full Text] [Related]
24. Inverse expression of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma.
Wang LS; Chow KC; Wu YC; Lin TY; Li WY
Int J Cancer; 2004 Aug; 111(2):246-51. PubMed ID: 15197778
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.
Sivula A; Buskens CJ; van Rees BP; Haglund C; Offerhaus GJ; van Lanschot JJ; Ristimäki A
Int J Cancer; 2005 Oct; 116(6):903-8. PubMed ID: 15856454
[TBL] [Abstract][Full Text] [Related]
27. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of mannose-binding lectin-associated serine protease-2 expression in esophageal squamous cell carcinoma.
Verma A; Matta A; Shukla NK; Deo SV; Gupta SD; Ralhan R
Int J Cancer; 2006 Jun; 118(12):2930-5. PubMed ID: 16395704
[TBL] [Abstract][Full Text] [Related]
30. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey.
Ratnasinghe D; Tangrea J; Roth MJ; Dawsey S; Hu N; Anver M; Wang QH; Taylor PR
Anticancer Res; 1999; 19(1A):171-4. PubMed ID: 10226539
[TBL] [Abstract][Full Text] [Related]
31. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells.
Wang LS; Chow KC; Wu YC
Scand J Gastroenterol; 2002 Apr; 37(4):467-75. PubMed ID: 11989839
[TBL] [Abstract][Full Text] [Related]
32. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas.
Tanaka H; Kijima H; Tokunaga T; Tajima T; Himeno S; Kenmochi T; Oshiba G; Kise Y; Nishi T; Chino O; Shimada H; Machimura T; Tanaka M; Makuuchi H
Int J Oncol; 1999 Jun; 14(6):1069-73. PubMed ID: 10339659
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression in human esophageal carcinoma.
Zimmermann KC; Sarbia M; Weber AA; Borchard F; Gabbert HE; Schrör K
Cancer Res; 1999 Jan; 59(1):198-204. PubMed ID: 9892207
[TBL] [Abstract][Full Text] [Related]
34. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
[TBL] [Abstract][Full Text] [Related]
35. Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: immunohistochemical data from carcinomas and nearby noncancerous lesions.
Ishibashi Y; Dosaka-Akita H; Miyoshi E; Shindoh M; Miyamoto M; Kinoshita I; Miyazaki H; Itoh T; Kondo S; Nishimura M; Taniguchi N
Oncology; 2005; 69(4):301-10. PubMed ID: 16282710
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathology of cyclooxygenase-2 in neoplasia.
Fosslien E
Ann Clin Lab Sci; 2000 Jan; 30(1):3-21. PubMed ID: 10678579
[TBL] [Abstract][Full Text] [Related]
37. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
[TBL] [Abstract][Full Text] [Related]
38. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
[TBL] [Abstract][Full Text] [Related]
39. Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma.
Zhang L; Wu YD; Li P; Tu J; Niu YL; Xu CM; Zhang ST
World J Gastroenterol; 2011 Nov; 17(41):4572-80. PubMed ID: 22147962
[TBL] [Abstract][Full Text] [Related]
40. Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma.
Miyashita M; Makino H; Katsuta M; Nomura T; Shinji S; Kashiwabara M; Takahashi K; Kudo M; Ishiwata T; Naito Z; Tajiri T
J Nippon Med Sch; 2006 Dec; 73(6):308-13. PubMed ID: 17220580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
